Gut Microbiota Metagenomics for Chronic Liver Disease
NCT04339725 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3240
Last updated 2020-04-09
Summary
Gut microbiota modulation has effect on chronic liver disease
Conditions
- Liver Disease Chronic
Interventions
- OTHER
-
DNA extraction
Extraction fecal DNA and compare disease group to normal group
Sponsors & Collaborators
-
Chuncheon Sacred Heart Hospital
lead OTHER
Eligibility
- Min Age
- 31 Years
- Max Age
- 82 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-04-01
- Primary Completion
- 2020-03-01
- Completion
- 2025-01-01
Countries
- South Korea
Study Locations
More Related Trials
-
Clinical Features and Natural History of Acute-on-Chronic Liver Failure in Korean Patients With Chronic Liver Disease
NCT02650011 ·Status: SUSPENDED
-
Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101)
NCT04883177 ·Status: COMPLETED
-
Study Of Bacterial/Fungal Infections in Hospitalized Patients With Liver Cirrhosis in China
NCT03676777 ·Status: UNKNOWN
-
Pathogenic Metagenomic Next-generation Sequencing to Optimize the Diagnosis of Decompensated Cirrhosis Infection
NCT06039696 ·Status: RECRUITING
-
Screening for Chronic Liver Diseases in General Population
NCT06366425 ·Status: RECRUITING ·Phase: NA
-
Fecal Microbiota Transplantation in Cirrhosis
NCT04591522 ·Status: UNKNOWN ·Phase: NA
-
To Study the Effects of Host Genetic Factors on Liver Cirrhosis and Hepatocellular Carcinoma (HCC)
NCT00709085 ·Status: UNKNOWN
-
"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".
NCT04690972 ·Status: RECRUITING
-
The Utility of Cell-free Methylation Markers in Blood for Hepatocellular Carcinoma
NCT05576571 ·Status: UNKNOWN
-
Efficacy, Safety, and Adequacy of EUS-guided Liver Biopsy
NCT04055870 ·Status: COMPLETED
-
Gut Microbiota and Modulation of Liver Damage in NAFLD
NCT02158351 ·Status: COMPLETED
-
Abbreviated MRI for HCC Surveillance
NCT03731923 ·Status: UNKNOWN ·Phase: NA
-
The Association With Peptic Ulcer Disease and Hepatic Vein Pressure Gradient
NCT01944878 ·Status: COMPLETED
-
Impact of FMT on the Phenome in Patients With NAFLD and Fibrosis
NCT06024681 ·Status: COMPLETED ·Phase: NA
-
Cognitive Function of Alcoholic Compensated Liver Cirrhosis
NCT04557774 ·Status: COMPLETED
-
Long Term Follow-Up Study of Immuncell-LC Group and Non-Treatment Group in Hepatocellular Carcinoma Patients.
NCT01890291 ·Status: COMPLETED
-
Polymorphisms of Fibrosis-Relating Genes on Outcome of HCV-Related Chronic Liver Disease
NCT00629603 ·Status: COMPLETED ·Phase: NA
-
Non-invasive Evaluation of Liver Fibrosis, Steatosis, and NASH in NAFLD
NCT03725631 ·Status: UNKNOWN ·Phase: NA
-
Effects of Hepatic Fibrosis on Hepatic Steatosis Using the Ultrasound Attenuation Imaging in Chronic Hepatitis B
NCT05871749 ·Status: COMPLETED
-
Research on the Clinical Characteristics and Key Diagnosis and Treatment Technology of Genetic and Metabolic Liver Disease
NCT05601557 ·Status: UNKNOWN
-
Hepatobiliary Tumors Tissue Samples Acquisition
NCT04445532 ·Status: UNKNOWN
-
Study on Proteomic and Microbiome Changes in Patients With Hepatic Encephalopathy (HE)
NCT07150195 ·Status: NOT_YET_RECRUITING
-
Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liver Failure
NCT07275554 ·Status: RECRUITING
-
COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study
NCT04329559 ·Status: COMPLETED
-
Impact of Hepatitis C Virus Variability on Steatosis
NCT00843076 ·Status: TERMINATED